Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.

de Vries, Rory D

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial. [electronic resource] - The Journal of infectious diseases 07 2018 - 614-623 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

1537-6613

10.1093/infdis/jiy214 doi


Adult
Antibodies, Viral--blood
Antibody-Dependent Cell Cytotoxicity
Cross Reactions
Double-Blind Method
Drug Carriers
Female
Hemagglutination Inhibition Tests
Hemagglutinin Glycoproteins, Influenza Virus--genetics
Humans
Immunization Schedule
Influenza A Virus, H5N1 Subtype--genetics
Influenza Vaccines--administration & dosage
Influenza, Human--prevention & control
Male
Neutralization Tests
Protein Array Analysis
T-Lymphocytes--immunology
Vaccines, Synthetic--administration & dosage
Vaccinia virus--genetics
Young Adult